Scholarlink

<p>Mucins play a pivotal role in the pathophysiology of mucoobstructive lung diseases. Accurate quantification of total mucin concentrations in clinical sputum samples is critical for developing objective biomarkers for diagnosis, prognosis, and therapeutic monitoring. By using sputum samples and mucin standards, the analytical performance of the measurements of total mucin concentration by Size Exclusion Chromatography coupled with Multi-Angle Laser Light Scattering and Differential Refractometer [SEC-(MALLS)-dRI] method was assessed using universal validation metrics, including precision, accuracy, recovery, parallelism, specificity, linearity, and sample stability. Possible sample contamination sources, such as saliva, blood, and DNA, were also evaluated. The method demonstrated excellent precision across low, medium, and high concentrations (CV% ≤ 2.6%) and high recovery (116%). It exhibited strong linearity over a broad dynamic range (~30–15,000&#xa0;µg/mL) and stability for up to 12&#xa0;months at − 20&#xa0;°C in naïve samples and 4&#xa0;°C in 4&#xa0;M GuHCl. Measurement interference was negligible, up to 20% saliva, 2% blood, and 2% DNA. This study validates the SEC-(MALLS)-dRI method as a robust, reliable approach for quantifying total mucin concentrations in clinical sputum samples. The demonstrated analytical validity establishes its use as a biomarker platform for clinical and research applications, aiding in the diagnosis and management of hypersecretory/mucoobstructive lung diseases.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Analytical validation of total mucin concentration assay using SEC MALLS dRI for diagnosing and monitoring mucoobstructive lung diseases

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月29日

查看全文
  • Esin Ozkan,
  • Stephanie Sue Livengood,
  • Amina Ahmad Ford,
  • Jade Kathryn Macdonald,
  • Sophia Samir,
  • Ian William Klevans,
  • Mehmet Kesimer

摘要

Mucins play a pivotal role in the pathophysiology of mucoobstructive lung diseases. Accurate quantification of total mucin concentrations in clinical sputum samples is critical for developing objective biomarkers for diagnosis, prognosis, and therapeutic monitoring. By using sputum samples and mucin standards, the analytical performance of the measurements of total mucin concentration by Size Exclusion Chromatography coupled with Multi-Angle Laser Light Scattering and Differential Refractometer [SEC-(MALLS)-dRI] method was assessed using universal validation metrics, including precision, accuracy, recovery, parallelism, specificity, linearity, and sample stability. Possible sample contamination sources, such as saliva, blood, and DNA, were also evaluated. The method demonstrated excellent precision across low, medium, and high concentrations (CV% ≤ 2.6%) and high recovery (116%). It exhibited strong linearity over a broad dynamic range (~30–15,000 µg/mL) and stability for up to 12 months at − 20 °C in naïve samples and 4 °C in 4 M GuHCl. Measurement interference was negligible, up to 20% saliva, 2% blood, and 2% DNA. This study validates the SEC-(MALLS)-dRI method as a robust, reliable approach for quantifying total mucin concentrations in clinical sputum samples. The demonstrated analytical validity establishes its use as a biomarker platform for clinical and research applications, aiding in the diagnosis and management of hypersecretory/mucoobstructive lung diseases.